Gena Wang
Stock Analyst at Barclays
(3.39)
# 2,378
Out of 4,988 analysts
743
Total ratings
43.9%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Gena Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Initiated Coverage: Buy | $8 → $9 | $3.05 | +195.08% | 15 | May 28, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $71 → $87 | $74.13 | +17.36% | 5 | Dec 21, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $81 → $50 | $26.49 | +88.75% | 42 | Nov 24, 2025 | |
| MRNA Moderna | Maintained: Hold | $25 | $63.32 | -60.52% | 31 | Nov 21, 2025 | |
| KOD Kodiak Sciences | Maintained: Hold | $17 | $41.35 | -58.89% | 27 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintained: Buy | $94 → $90 | $20.37 | +341.83% | 27 | Nov 13, 2025 | |
| EDIT Editas Medicine | Maintained: Hold | $3 | $2.82 | +6.38% | 31 | Nov 11, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintained: Hold | $56 | $53.55 | +4.58% | 27 | Nov 11, 2025 | |
| VIR Vir Biotechnology | Maintained: Buy | $31 | $9.24 | +235.50% | 24 | Nov 11, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | $414 | $505.75 | -18.14% | 36 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $12.19 | +170.71% | 12 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.175 | +471.43% | 27 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 | $8.83 | -77.35% | 22 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $10.77 | +243.71% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $385 | $347.48 | +10.80% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $14 | $11.91 | +17.55% | 33 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $20 | $18.10 | +10.50% | 64 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $68 | $71.70 | -5.16% | 51 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $26.75 | -21.50% | 22 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $9 | $9.74 | -7.60% | 26 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $9.20 | -2.17% | 19 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 → $527 | $228.65 | +130.48% | 55 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $95 | $57.24 | +65.97% | 30 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $80 | $67.34 | +18.80% | 35 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 → $62 | $12.84 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 → $48 | $34.91 | n/a | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $25.12 | n/a | 13 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $16 → $25 | $8.23 | n/a | 12 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $18 | $13.52 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $6 | $7.43 | n/a | 3 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $21 | $62.14 | n/a | 3 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $21 | $98.66 | n/a | 7 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $8.09 | n/a | 5 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $5.99 | n/a | 1 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $803.48 | n/a | 1 | Aug 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $26.79 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $48.62 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $56 | $1.02 | n/a | 2 | Mar 17, 2015 |
Cellectis
May 28, 2026
Initiated Coverage: Buy
Price Target: $8 → $9
Current: $3.05
Upside: +195.08%
Cytokinetics
Dec 21, 2025
Maintained: Buy
Price Target: $71 → $87
Current: $74.13
Upside: +17.36%
Ultragenyx Pharmaceutical
Nov 24, 2025
Maintained: Buy
Price Target: $81 → $50
Current: $26.49
Upside: +88.75%
Moderna
Nov 21, 2025
Maintained: Hold
Price Target: $25
Current: $63.32
Upside: -60.52%
Kodiak Sciences
Nov 17, 2025
Maintained: Hold
Price Target: $17
Current: $41.35
Upside: -58.89%
Legend Biotech
Nov 13, 2025
Maintained: Buy
Price Target: $94 → $90
Current: $20.37
Upside: +341.83%
Editas Medicine
Nov 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.82
Upside: +6.38%
CRISPR Therapeutics AG
Nov 11, 2025
Maintained: Hold
Price Target: $56
Current: $53.55
Upside: +4.58%
Vir Biotechnology
Nov 11, 2025
Maintained: Buy
Price Target: $31
Current: $9.24
Upside: +235.50%
Vertex Pharmaceuticals
Nov 10, 2025
Maintained: Hold
Price Target: $414
Current: $505.75
Upside: -18.14%
Nov 10, 2025
Maintained: Buy
Price Target: $38 → $33
Current: $12.19
Upside: +170.71%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $1
Current: $0.175
Upside: +471.43%
Nov 7, 2025
Maintained: Sell
Price Target: $2
Current: $8.83
Upside: -77.35%
Nov 7, 2025
Maintained: Buy
Price Target: $37
Current: $10.77
Upside: +243.71%
Nov 7, 2025
Maintained: Buy
Price Target: $385
Current: $347.48
Upside: +10.80%
Nov 7, 2025
Maintained: Buy
Price Target: $24 → $14
Current: $11.91
Upside: +17.55%
Nov 5, 2025
Maintained: Hold
Price Target: $22 → $20
Current: $18.10
Upside: +10.50%
Nov 5, 2025
Maintained: Hold
Price Target: $46 → $68
Current: $71.70
Upside: -5.16%
Nov 5, 2025
Maintained: Hold
Price Target: $21
Current: $26.75
Upside: -21.50%
Nov 3, 2025
Maintained: Hold
Price Target: $11 → $9
Current: $9.74
Upside: -7.60%
Nov 3, 2025
Maintained: Buy
Price Target: $10 → $9
Current: $9.20
Upside: -2.17%
Oct 31, 2025
Maintained: Buy
Price Target: $460 → $527
Current: $228.65
Upside: +130.48%
Oct 30, 2025
Maintained: Buy
Price Target: $80 → $95
Current: $57.24
Upside: +65.97%
Oct 28, 2025
Maintained: Buy
Price Target: $86 → $80
Current: $67.34
Upside: +18.80%
Aug 7, 2025
Maintained: Buy
Price Target: $59 → $62
Current: $12.84
Upside: n/a
Aug 10, 2023
Rated: Buy
Price Target: $4 → $48
Current: $34.91
Upside: n/a
Dec 22, 2022
Maintained: Hold
Price Target: $7 → $9
Current: $25.12
Upside: n/a
Nov 2, 2022
Upgraded: Hold
Price Target: $16 → $25
Current: $8.23
Upside: n/a
May 13, 2022
Maintained: Buy
Price Target: $32 → $18
Current: $13.52
Upside: n/a
Mar 15, 2022
Maintained: Buy
Price Target: $18 → $6
Current: $7.43
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $19 → $21
Current: $62.14
Upside: n/a
May 12, 2020
Maintained: Hold
Price Target: $20 → $21
Current: $98.66
Upside: n/a
Jun 22, 2017
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $8.09
Upside: n/a
Jan 20, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $5.99
Upside: n/a
Aug 17, 2016
Reiterated: Hold
Price Target: n/a
Current: $803.48
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $26.79
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $48.62
Upside: n/a
Mar 17, 2015
Reiterated: Buy
Price Target: $23 → $56
Current: $1.02
Upside: n/a